Latest & greatest articles for corticosteroids

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on corticosteroids or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on corticosteroids and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for corticosteroids

41. Benefits and harms of antenatal corticosteroids: individual participant meta-analysis of observational data

Benefits and harms of antenatal corticosteroids: individual participant meta-analysis of observational data Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files

2019 PROSPERO

42. The effects of corticosteroids on the respiratory microbiome: a systematic review

The effects of corticosteroids on the respiratory microbiome: a systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email

2019 PROSPERO

43. Different strategies for using topical corticosteroids in people with eczema [Cochrane protocol]

Different strategies for using topical corticosteroids in people with eczema [Cochrane protocol] Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external

2019 PROSPERO

44. Platelet-rich plasma versus corticosteroids for elbow epicondylitis: a meta-analysis

Platelet-rich plasma versus corticosteroids for elbow epicondylitis: a meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites

2019 PROSPERO

45. Prophylactic corticosteroids for paediatric heart surgery with cardiopulmonary bypass [Cochrane protocol]

Prophylactic corticosteroids for paediatric heart surgery with cardiopulmonary bypass [Cochrane protocol] Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files

2019 PROSPERO

46. A systematic review of the efficacy of available therapeutic agents used to achieve remission in moderate-to-severe ulcerative colitis, deemed dependent upon- or refractory to- treatment with corticosteroids and simple immunomodulatory therapy

A systematic review of the efficacy of available therapeutic agents used to achieve remission in moderate-to-severe ulcerative colitis, deemed dependent upon- or refractory to- treatment with corticosteroids and simple immunomodulatory therapy Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission

2019 PROSPERO

47. A systematic review to quantify the pharmacodynamics effects of inhaled corticosteroids on adrenal function

A systematic review to quantify the pharmacodynamics effects of inhaled corticosteroids on adrenal function Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files

2019 PROSPERO

48. Efficacy and tolerability of systemic versus intratympanic corticosteroid in the treatment of idiopathic sudden sensorineural hearing loss: a systematic review and meta-analysis

Efficacy and tolerability of systemic versus intratympanic corticosteroid in the treatment of idiopathic sudden sensorineural hearing loss: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability

2019 PROSPERO

49. Intratympanic corticosteroid as salvage therapy in treatment of idiopathic sudden sensorineural hearing loss: a systematic review and meta-analysis

Intratympanic corticosteroid as salvage therapy in treatment of idiopathic sudden sensorineural hearing loss: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content

2019 PROSPERO

50. Clinical efficacy of intralesional botulinum toxin type a monotherapy or combination therapy with corticosteroid to inhibit hypertrophic scar and keloid: a meta-analysis

Clinical efficacy of intralesional botulinum toxin type a monotherapy or combination therapy with corticosteroid to inhibit hypertrophic scar and keloid: a meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability

2019 PROSPERO

51. Effectiveness of intra-articular corticosteroids in internal disorders of the temporomandibular joint: systematic review and network meta-analysis

Effectiveness of intra-articular corticosteroids in internal disorders of the temporomandibular joint: systematic review and network meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content

2019 PROSPERO

52. Postnatal corticosteroids for transient tachypnea of the newborn [Cochrane protocol]

Postnatal corticosteroids for transient tachypnea of the newborn [Cochrane protocol] Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites

2019 PROSPERO

53. Emollients and topical corticosteroids for treatment of atopic dermatitis: a systematic review of guidelines

Emollients and topical corticosteroids for treatment of atopic dermatitis: a systematic review of guidelines Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files

2019 PROSPERO

54. As needed combined long acting beta agonists and inhaled corticosteroids in mild asthma: meta-analysis and systematic review

As needed combined long acting beta agonists and inhaled corticosteroids in mild asthma: meta-analysis and systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any

2019 PROSPERO

55. Non-corticosteroid adjuvant therapies for acute bacterial meningitis [Cochrane protocol]

Non-corticosteroid adjuvant therapies for acute bacterial meningitis [Cochrane protocol] Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites

2019 PROSPERO

56. Consequences of long-term oral corticosteroid therapy and its side-effects in severe asthma in adults: a focused review of the impact data in the literature

Consequences of long-term oral corticosteroid therapy and its side-effects in severe asthma in adults: a focused review of the impact data in the literature This review provides an overview of the role of long-term treatment of severe asthma with oral corticosteroids (OCS) and its associated side-effects in adults. It is based on a systematic literature search conducted in MEDLINE, Embase and the Cochrane Library to identify relevant studies. After a short overview of severe asthma and its (...) , studies showed a significant increase in healthcare resource utilisation due to OCS treatment. Therefore, it is incumbent on every clinician to carefully weigh the potential benefit of preventing loss of asthma control against this risk before opting to prescribe long-term OCS therapy. Effective corticosteroid-sparing strategies must be used and should aim at short-term use with the lowest effective dose and start tapering as soon as possible until OCS therapy is terminated.Copyright ©ERS 2018.

2018 EvidenceUpdates

57. Corticosteroids for septic arthritis in children. (PubMed)

Corticosteroids for septic arthritis in children. Septic arthritis is an acute infection of the joints characterised by erosive disruption of the articular space. It is the most common non-degenerative articular disease in developing countries. The most vulnerable population for septic arthritis includes infants and preschoolers, especially boys. Septic arthritis disproportionately affects populations of low socioeconomic status. Systemic corticosteroids and antibiotic therapy may be beneficial (...) for treatment of septic arthritis. Even if the joint infection is eradicated by antibiotic treatment, the inflammatory process may produce residual joint damage and sequelae.To determine the benefits and harms of corticosteroids as adjunctive therapy in children with a diagnosis of septic arthritis.We searched MEDLINE, Embase, the Cochrane Central Register of Controlled Trials (CENTRAL), in the Cochrane Library, Latin American Caribbean Health Sciences Literature (LILACS), the World Health Organization (WHO

2018 Cochrane

58. Saline irrigation and corticosteroid spray are effective first choice treatments for chronic sinusitis

Saline irrigation and corticosteroid spray are effective first choice treatments for chronic sinusitis Saline irrigation and corticosteroid spray are effective first choice treatments for chronic sinusitis Discover Portal Discover Portal Saline irrigation and corticosteroid spray are effective first choice treatments for chronic sinusitis Published on 22 December 2015 doi: The authors of this systematic review found that high-volume saline irrigation and corticosteroid nasal sprays were (...) effective at reducing symptoms of sinusitis. They recommend a combination of these two therapies as the first line treatment of choice, in accordance with guidelines from the Royal College of Surgeons and ENT UK. In addition they found that, in those with nasal polyps, corticosteroids sprays reduced the polyp size, and during acute exacerbations a two to three week course of oral corticosteroids, doxycycline or a leukotriene antagonist was the most effective strategy. For those without polyps a three

2018 NIHR Dissemination Centre

59. Are Corticosteroids Superior to Nonsteroidal Anti-inflammatory Drugs in the Treatment of Acute Gout? (SRS Therapy)

Are Corticosteroids Superior to Nonsteroidal Anti-inflammatory Drugs in the Treatment of Acute Gout? (SRS Therapy) TAKE-HOME MESSAGE Corticosteroids provide pain relief similar to that of nonsteroidal anti- in?ammatory drugs for acute gout, with fewer adverse effects. Are Corticosteroids Superior to Nonsteroidal Anti-in?ammatory Drugs in the Treatment of Acute Gout? EBEM Commentators Joseph W. Watkins IV, MD Rawle A. Seupaul, MD Department of Emergency Medicine University of Arkansas (...) for Medical Sciences Little Rock, AR Results The search identi?ed 529 refer- ences; 6 trials evaluating 817 pa- tients met inclusion criteria. The overallriskofbiaswaslowinthese trials, whereas the quality of the evidence was rated as low to mod- erate according to GRADE criteria. Themeta-analysisdemonstratedno difference between corticosteroids and nonsteroidal anti-in?ammatory drugs for the following outcomes: short-term pain relief ( 7days), time to resolution of pain, and requirement for additional

2018 Annals of Emergency Medicine Systematic Review Snapshots

60. Are Corticosteroids Beneficial in the Treatment of Community-Acquired Pneumonia? (SRS Therapy)

Are Corticosteroids Beneficial in the Treatment of Community-Acquired Pneumonia? (SRS Therapy) TAKE-HOME MESSAGE For adult patients with severe community-acquired pneumonia, corticosteroids reduce morbidity and mortality. For pediatric patients and adults with nonsevere community-acquired pneumonia, corticosteroids appear to reduce morbidity, but not mortality. Are Corticosteroids Bene?cial in the Treatment of Community-Acquired Pneumonia? EBEM Commentators Thomas Seagraves, MD Michael Gottlieb (...) , MD Department of Emergency Medicine Rush University Medical Center Chicago, IL Results Comparison of corticosteroids with control for community-acquired pneumonia. Outcome No. of Studies (No. of Participants) Relative Risk (95% CI) I 2 ,% Mortality (adults with severe CAP) 9 (995) 0.58 (0.40–0.84) 12 Mortality (adults with nonsevere CAP) 4 (868) 0.95 (0.45–2.00) 0 Early clinical failure (adults with severe CAP) 5 (419) 0.32 (0.15–0.70) 74 Early clinical failure (adults with nonsevere CAP) 2 (905

2018 Annals of Emergency Medicine Systematic Review Snapshots